176 related articles for article (PubMed ID: 9489976)
61. Safety and efficacy of isradipine, alone and in combination, in the treatment of angina pectoris.
Rüegg PC; Nelson DJ
Am J Med; 1989 Apr; 86(4A):70-4. PubMed ID: 2565689
[TBL] [Abstract][Full Text] [Related]
62. Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists.
Mitrovic V; Oehm E; Thormann J; Pitschner H; Hamm C
Herz; 2000 Mar; 25(2):130-42. PubMed ID: 10829253
[TBL] [Abstract][Full Text] [Related]
63. Profound symptomatic bradycardia associated with combined mibefradil and beta-blocker therapy.
Rogers R; Prpic R
Med J Aust; 1998 Oct; 169(8):425-7. PubMed ID: 9830391
[TBL] [Abstract][Full Text] [Related]
64. Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists.
Massie BM; Lacourcière Y; Viskoper R; Woittiez A; Kobrin I
Am J Cardiol; 1997 Aug; 80(4B):27C-33C. PubMed ID: 9286851
[TBL] [Abstract][Full Text] [Related]
65. Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris.
Shlyakhto EV; Almazov VV; Nifontov EM; Vakhrameyeva IV; Rudomanov OG; Zakharov DV; Kazarin VV; Vakhrameyeva NV
Am J Cardiovasc Drugs; 2002; 2(2):119-24. PubMed ID: 14727987
[TBL] [Abstract][Full Text] [Related]
66. Mibefradil: a selective T-type calcium antagonist.
Massie BM
Am J Cardiol; 1997 Nov; 80(9A):23I-32I. PubMed ID: 9375939
[TBL] [Abstract][Full Text] [Related]
67. The antihypertensive efficacy of the novel calcium antagonist mibefradil in comparison with nifedipine GITS in moderate to severe hypertensives with ambulatory hypertension.
Lacourcière Y; Poirier L; Lefebvre J; Archambault F; Dalle Ave S; Ward C; Lindberg E
Am J Hypertens; 1997 Feb; 10(2):189-96. PubMed ID: 9037327
[TBL] [Abstract][Full Text] [Related]
68. Combination therapy with calcium-channel blockers and beta blockers for chronic stable angina pectoris.
Leon MB; Rosing DR; Bonow RO; Epstein SE
Am J Cardiol; 1985 Jan; 55(3):69B-80B. PubMed ID: 2857518
[TBL] [Abstract][Full Text] [Related]
69. Mibefradil release expands calcium-channel-blocker choices.
Am J Health Syst Pharm; 1997 Sep; 54(18):2033. PubMed ID: 9377200
[No Abstract] [Full Text] [Related]
70. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
71. Mibefradil, a T-channel-selective calcium antagonist: clinical trials in hypertension.
Oparil S
Am J Hypertens; 1998 Apr; 11(4 Pt 3):88S-94S. PubMed ID: 9607372
[TBL] [Abstract][Full Text] [Related]
72. The acute effects of intravenously administered mibefradil, a new calcium antagonist, on the electrophysiologic characteristics of the human heart.
Rosenquist M; Brembilla-Perrot B; Meinertz T; Neugebauer A; Crijns HJ; Smeets JL; van der Vring JA; Fromer M; Kobrin I
Eur J Clin Pharmacol; 1997; 52(1):7-12. PubMed ID: 9143860
[TBL] [Abstract][Full Text] [Related]
73. [Mibefradil: a new class calcium inhibitor].
Internist (Berl); 1996 Oct; 37(10 Suppl Mibefradil):1-8. PubMed ID: 9402420
[No Abstract] [Full Text] [Related]
74. [Mibefradil opens up a new class of calcium antagonists. Glasgow, 23 June 1996].
Dtsch Med Wochenschr; 1996 Sep; 121(39 Suppl):1-4. PubMed ID: 9212757
[No Abstract] [Full Text] [Related]
75. Hemolysis on intravenous administration of a new calcium antagonist.
Kleinbloesem CH; Siepmann M; Kirch W
J Cardiovasc Pharmacol; 1995 Jun; 25(6):855-8. PubMed ID: 7564328
[TBL] [Abstract][Full Text] [Related]
76. Mibefradil--a new calcium-channel blocker.
Med Lett Drugs Ther; 1997 Nov; 39(1013):103-5. PubMed ID: 9391500
[No Abstract] [Full Text] [Related]
77. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
Thadani U; Ezekowitz M; Fenney L; Chiang YK
Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
[TBL] [Abstract][Full Text] [Related]
78. Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockers.
Uusitalo A
Drugs; 1987; 33 Suppl 4():111-7. PubMed ID: 2887418
[TBL] [Abstract][Full Text] [Related]
79. Efficacy of monotherapy compared with combined antianginal drugs in the treatment of chronic stable angina pectoris: a meta-analysis.
Klein WW; Jackson G; Tavazzi L
Coron Artery Dis; 2002 Dec; 13(8):427-36. PubMed ID: 12544718
[TBL] [Abstract][Full Text] [Related]
80. Combined use of calcium-channel and beta-adrenergic blockers for the treatment of chronic stable angina. Rationale, efficacy, and adverse effects.
Strauss WE; Parisi AF
Ann Intern Med; 1988 Oct; 109(7):570-81. PubMed ID: 2901816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]